Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancer.

Clinical validation of Ki67 by quantitative reverse transcription-polymerase chain reaction (RT-PCR) in HR+/HER2- early breast cancer. — المؤلف: Gao, Weiqi — Journal of Cancer 2019

المؤلف
Gao, Weiqi
النشر
Journal of Cancer 2019
الوصف
1110-1116 p.